Drug
Ramelteon
Ramelteon: highest development phase Post-Market, developed by Takeda. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ramelteon NCT00622427 | Post-Market | ADHD With Sleep Onset Insomnia |
Latest
No recent events.
Follow Ramelteon on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.